- Home
- / Texas A&M Health Science Center
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Texas A&M Health Science Center financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$278.6 M
FY, 2020
CreditSafe Score
?
Score changed on Jun 18, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 140.4M | 144.8M | 278.6M |
| Revenue growth, % | 3.1% | 92.4% | |
| Operating expense total | 295.8M | 307.0M | 457.6M |
| Depreciation and amortization | 18.2M | 20.0M | 26.6M |
| EBIT | (155.4M) | (162.2M) | (178.9M) |
| EBIT margin, % | -110.7% | -112.0% | -64.2% |
| Investment income | 15.9M | 9.4M | 31.9M |
| Interest expense | 7.5K | 2.9K | |
| Net Income | 78.7M | 141.8M | 150.6M |